Star Combo Pharma Ltd (S66) — Capital Reinvestment Ratio
Latest as of December 2025:
0.51x
Star Combo Pharma Ltd (S66) has a Capital Reinvestment Ratio of 0.51x as of December 2025, meaning it reinvests 1% of its operating cash flow (AU$575.23K) in capital expenditures (AU$295.53K). See Star Combo Pharma Ltd (S66) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.51x
Capex / Operating Cash Flow
Operating Cash Flow
AU$575.23K
AUD
Capital Expenditures
AU$295.53K
AUD
Data as of
Dec 2025
Most recent filing
Star Combo Pharma Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks Star Combo Pharma Ltd's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Star Combo Pharma Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for Star Combo Pharma Ltd from 2016 to 2025. For live market cap and broader valuation context, see market value of Star Combo Pharma Ltd.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | AU$11.94 Million | AU$393.72K | ▼ -97.7% |
| 2023 | 1.45x | AU$1.88 Million | AU$2.73 Million | ▼ -98.3% |
| 2022 | 83.74x | AU$87.11K | AU$7.29 Million | ▲ +282.5% |
| 2021 | 21.89x | AU$331.53K | AU$7.26 Million | ▲ +7714.6% |
| 2017 | 0.28x | AU$932.20K | AU$261.13K | ▼ -68.3% |
| 2016 | 0.88x | AU$1.30 Million | AU$1.15 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow